CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed
Drug / intervention
5-fluorouracil +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00346489
NCT00346489Phase 4Completed
CompareCT.gov

Intermediate Term Outcomes of Intraoperative 5-Fluorouracil Versus Mitomycin c in Trabeculectomy Surgery.

Indiana University·interventional·Posted Jun 30, 2006·Updated Dec 27, 2007

In Brief

A Phase 4 clinical trial evaluating 5-fluorouracil and Mitomycin C for Glaucoma. Completed, across 2 sites.

Detailed Summary

A clinical trial to establish the long term response of using intraoperative 5-fluorouracil (5-FU) versus mitomycin C (MMC) in trabeculectomy glaucoma surgery. Antiproliferative agents such as 5-fluorouracil and Mitomycin C have been used extensively in trabeculectomy surgery to improve the success of the surgery and prevent further visual loss and blindness in glaucoma patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGlaucoma
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 30, 2006
Enrollment StartSep 1, 2004
Primary CompletionAug 1, 2007
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 20.0 years ago

Interventions

5-fluorouracildrug

Mitomycin Cdrug